Veteran owned small business Spartan Medical Inc revealed on Wednesday that it plans to introduce Altapure LLC's AP-4 High-level Disinfection-System (HLDS) across the US market in the fight against COVID-19.
This critically needed, AP-4 advanced-ultrasonic-technology ensures that all healthcare and long-term care facilities, schools, universities, cruise lines, among others, can provide the cleanest/safest environment to fellow Americans. Altapure's first fully integrated high-level disinfection system AP–4 Medical HLD System will eliminate all bacteria, spores and viruses in a treated space. The system is easily operated by one person and many facilities have one person running two to three machines at a time.
The AP–4 is a single mobile unit platform, containing a combined submicron aerosol output device and environmental air re-processor system with data feedback. The process's agent is organic, biodegradable, food safe and leaves zero residue. Its PAA agent is an EPA registered cold sterilant, bactericide, fungicide, virucide and sporicide. In short, there has not yet been a pathogen that can survive the disinfection cycle, making the implementation of this state-of-the-art solution paramount during COVID-19 and beyond.
In collaboration with NASA, Altapure has shown efficacy in the sterilization of PPE with the 'peracetic acid technology.
Creo Medical secures FDA clearance for SpydrBlade Flex in US market
Tissue Regenix secures CE and UKCA certifications for OrthoPure XT
Terumo Corporation expands stroke portfolio in EMEA with SOFIA Flow 88 catheter launch
Crossject advances ZENEO manufacturing with scalable aseptic filling module ahead of product rollout
Mindray unveils BeneVision V Series at Euroanaesthesia 2025, advancing precision monitoring
Unicon Pharma and VRR Life Sciences partner support digital transformation in life sciences
Median Technologies submits 510(k) application for eyonis LCS lung cancer screening software
Tristel secures FDA clearance for Ophthalmic Disinfectant Tristel OPH